Last reviewed · How we verify
NCT06871293
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
NA trial testing Functional and cognitive rehabilitation strategy in Long COVID-19 Syndrome in 374 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Fundación Cardioinfantil Instituto de Cardiología |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 374 |
| Start date | 30 October 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 1 January 2027 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Functional and cognitive rehabilitation strategy
- Evidence-Based Informational Support
Conditions studied
- Long COVID-19 Syndrome — all drugs for Long COVID-19 Syndrome →
- COVID 19 — all drugs for COVID 19 →
- Noncommunicable Disease — all drugs for Noncommunicable Disease →
- Hypertension — all drugs for Hypertension →
Sponsor
Fundación Cardioinfantil Instituto de Cardiología — full company profile →
Who can join
Adults 18 to 80, any sex, with Long COVID-19 Syndrome or COVID 19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19. Researchers will compare a structured rehabilitation program to informational support through evidence-based messages to determine if rehabilitation leads to better functional and cognitive outcomes in patients with Long Covid-19. Participants will be randomly assigned to one of two groups: 1. Functional and cognitive rehabilitation: Attending weekly in-person sessions for 8 weeks, including supervised physical and cognitive exercises. 2. Informational support: Receiving weekly evidence-based educational messages for 8 weeks. Participants will undergo assessments at baseline, post-intervention, and six months later, including a six-minute walk test, handgrip strength measurement, and questionnaires on disability, anxiety, depression, fatigue, dyspnea, cognitive function, and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06871293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Long COVID-19 Syndrome
Currently open trials in the same condition.
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07110714 — Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients · NA · recruiting
- NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · recruiting
- NCT07046442 — Effect of Pulmonary Rehabilitation and Physical Activity on Long COVID (PuReCOVID) · active not recruiting
Other Fundación Cardioinfantil Instituto de Cardiología trials
Trials by the same sponsor.
- NCT07035509 — Randomized Control Study in REsuscitation of SEpsis Trial · Phase 4 · not yet recruiting
- NCT06452901 — PROgressive struCturEd Simulation-based Surgical Training Program (PROCESS) - Open Vascular Surgery · NA · not yet recruiting
- NCT05147623 — Colombian Surgical Outcomes Study - COLSOS · unknown
- NCT04604665 — Evaluation of Two Levels of Frequency of Repositioning in the Reduction of Pressure Ulcers · NA · completed
- NCT03213496 — Promotion of Ambulation Before Non-cardiac Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06871293 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Cardioinfantil Instituto de Cardiología
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing